Literature DB >> 23709591

Neuro-ophthalmologic evaluation, quality of life, and functional disability in patients with MS.

Elena Garcia-Martin1, Diego Rodriguez-Mena, Raquel Herrero, Carmen Almarcegui, Isabel Dolz, Jesus Martin, Jose R Ara, Jose M Larrosa, Vicente Polo, Javier Fernández, Luis E Pablo.   

Abstract

OBJECTIVE: To evaluate correlations between longitudinal changes in neuro-ophthalmologic measures and quality of life (QOL) and disability in patients with multiple sclerosis (MS), using optical coherence tomography (OCT), visual evoked potentials (VEP), and visual field examination.
METHODS: Fifty-four patients with relapsing-remitting MS were enrolled in this study and underwent Multiple Sclerosis Quality of Life questionnaire (54 items) (MSQOL-54) and Expanded Disability Status Scale (EDSS) evaluation, as well as complete neuro-ophthalmologic examination including visual field testing and retinal nerve fiber layer (RNFL) measurements using Cirrus and Spectralis OCT and VEP. All patients were re-evaluated at 12, 24, and 36 months. Logistical regression was performed to analyze which measures, if any, could predict QOL.
RESULTS: Overall, RNFL thickness results at the baseline evaluation were significantly different from those at 3 years (p ≤ 0.05), but there were no differences in functional measures (visual acuity, contrast sensitivity, color vision, visual field, and VEP). A reduced MSQOL-54 score was associated with an increase in EDSS score and a decrease in both functional and structural parameters. Patients with longer MS duration presented with a lower MSQOL-54 score (reduction in QOL).
CONCLUSIONS: Patients with progressive axonal loss as seen in RNFL results had a lower QOL and more functional disability.

Entities:  

Mesh:

Year:  2013        PMID: 23709591     DOI: 10.1212/WNL.0b013e318299ccd9

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  26 in total

1.  How Common Is Signal-Intensity Increase in Optic Nerve Segments on 3D Double Inversion Recovery Sequences in Visually Asymptomatic Patients with Multiple Sclerosis?

Authors:  T Sartoretti; E Sartoretti; S Rauch; C Binkert; M Wyss; D Czell; S Sartoretti-Schefer
Journal:  AJNR Am J Neuroradiol       Date:  2017-06-29       Impact factor: 3.825

Review 2.  Monitoring the Course of MS With Optical Coherence Tomography.

Authors:  Alexander U Brandt; Elena H Martinez-Lapiscina; Rachel Nolan; Shiv Saidha
Journal:  Curr Treat Options Neurol       Date:  2017-04       Impact factor: 3.598

Review 3.  Evolution of Visual Outcomes in Clinical Trials for Multiple Sclerosis Disease-Modifying Therapies.

Authors:  Rachel C Nolan; Omar Akhand; John-Ross Rizzo; Steven L Galetta; Laura J Balcer
Journal:  J Neuroophthalmol       Date:  2018-06       Impact factor: 3.042

4.  Reliability and validity of Cirrus and Spectralis optical coherence tomography for detecting retinal atrophy in Alzheimer's disease.

Authors:  V Polo; E Garcia-Martin; M P Bambo; J Pinilla; J M Larrosa; M Satue; S Otin; L E Pablo
Journal:  Eye (Lond)       Date:  2014-03-14       Impact factor: 3.775

Review 5.  Visual Dysfunction in Multiple Sclerosis and its Animal Model, Experimental Autoimmune Encephalomyelitis: a Review.

Authors:  Taekyun Shin; Meejung Ahn; Jeongtae Kim; Kyungsook Jung; Changjong Moon; Moon-Doo Kim
Journal:  Mol Neurobiol       Date:  2021-03-20       Impact factor: 5.590

Review 6.  Past, present and future role of retinal imaging in neurodegenerative disease.

Authors:  Amir H Kashani; Samuel Asanad; Jane W Chan; Maxwell B Singer; Jiong Zhang; Mona Sharifi; Maziyar M Khansari; Farzan Abdolahi; Yonggang Shi; Alessandro Biffi; Helena Chui; John M Ringman
Journal:  Prog Retin Eye Res       Date:  2021-01-15       Impact factor: 19.704

Review 7.  Vision and vision-related outcome measures in multiple sclerosis.

Authors:  Laura J Balcer; David H Miller; Stephen C Reingold; Jeffrey A Cohen
Journal:  Brain       Date:  2014-11-28       Impact factor: 13.501

8.  Visual dysfunction and its correlation with retinal changes in patients with Parkinson's disease: an observational cross-sectional study.

Authors:  V Polo; M Satue; M J Rodrigo; S Otin; R Alarcia; M P Bambo; M I Fuertes; J M Larrosa; L E Pablo; E Garcia-Martin
Journal:  BMJ Open       Date:  2016-05-06       Impact factor: 2.692

9.  Relationship between Visual Dysfunction and Retinal Changes in Patients with Multiple Sclerosis.

Authors:  Maria Satue; Maria Jesus Rodrigo; Sofia Otin; Maria Pilar Bambo; Maria Isabel Fuertes; Jose Ramon Ara; Jesus Martin; Vicente Polo; Jose Manuel Larrosa; Luis Pablo; Elena Garcia-Martin
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

10.  Optimal Intereye Difference Thresholds in Retinal Nerve Fiber Layer Thickness for Predicting a Unilateral Optic Nerve Lesion in Multiple Sclerosis.

Authors:  Rachel C Nolan; Steven L Galetta; Teresa C Frohman; Elliot M Frohman; Peter A Calabresi; Carmen Castrillo-Viguera; Diego Cadavid; Laura J Balcer
Journal:  J Neuroophthalmol       Date:  2018-12       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.